- Home
- LAW vs DCTH Comparison
LAW vs DCTH Comparison
Compare LAW & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAW
- DCTH
- Stock Information
- Founded
- LAW 2013
- DCTH 1988
- Country
- LAW United States
- DCTH United States
- Employees
- LAW N/A
- DCTH N/A
- Industry
- LAW Computer Software: Prepackaged Software
- DCTH Medical/Dental Instruments
- Sector
- LAW Technology
- DCTH Health Care
- Exchange
- LAW Nasdaq
- DCTH Nasdaq
- Market Cap
- LAW 356.9M
- DCTH 387.2M
- IPO Year
- LAW 2021
- DCTH N/A
- Fundamental
- Price
- LAW $5.40
- DCTH $10.91
- Analyst Decision
- LAW Hold
- DCTH Strong Buy
- Analyst Count
- LAW 5
- DCTH 4
- Target Price
- LAW $7.10
- DCTH $21.50
- AVG Volume (30 Days)
- LAW 100.8K
- DCTH 363.4K
- Earning Date
- LAW 11-06-2024
- DCTH 11-08-2024
- Dividend Yield
- LAW N/A
- DCTH N/A
- EPS Growth
- LAW N/A
- DCTH N/A
- EPS
- LAW N/A
- DCTH N/A
- Revenue
- LAW $143,584,000.00
- DCTH $22,644,000.00
- Revenue This Year
- LAW $5.34
- DCTH $1,605.13
- Revenue Next Year
- LAW $4.77
- DCTH $111.67
- P/E Ratio
- LAW N/A
- DCTH N/A
- Revenue Growth
- LAW 6.45
- DCTH 945.91
- 52 Week Low
- LAW $4.71
- DCTH $3.43
- 52 Week High
- LAW $8.80
- DCTH $13.30
- Technical
- Relative Strength Index (RSI)
- LAW 36.55
- DCTH 57.95
- Support Level
- LAW $5.77
- DCTH $11.67
- Resistance Level
- LAW $6.64
- DCTH $13.30
- Average True Range (ATR)
- LAW 0.25
- DCTH 0.73
- MACD
- LAW -0.05
- DCTH 0.01
- Stochastic Oscillator
- LAW 1.58
- DCTH 34.60
About LAW CS Disco Inc.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.